In a cross-sectional study, monocyte subsets in placental, cord, and maternal peripheral blood from pregnant Malawian women with human immunodeficiency virus (HIV)-1 infection and/or malaria were analyzed. HIV-uninfected Malawian women had higher baseline proportions of CD16 + monocytes than those reported for healthy adults in developed countries. Malaria was associated with an increase in the proportion of CD16 + monocytes that was significant in women coinfected with HIV-1. CD16 + monocytes expressed higher CCR5 levels than did CD14 hi /CD16 Ϫ monocytes and were significantly more likely to harbor HIV-1. These data suggest a role for CD16 + monocytes in the pathogenesis of maternal malaria and HIV-1 infections.
B R I E F R E P O R T

CD16
+ Monocyte Subset Preferentially Harbors HIV-1 and Is Expanded in Pregnant Malawian Women with Plasmodium falciparum Malaria and HIV-1 Infection
In a cross-sectional study, monocyte subsets in placental, cord, and maternal peripheral blood from pregnant Malawian women with human immunodeficiency virus (HIV)-1 infection and/or malaria were analyzed. HIV-uninfected Malawian women had higher baseline proportions of CD16 + monocytes than those reported for healthy adults in developed countries. Malaria was associated with an increase in the proportion of CD16 + monocytes that was significant in women coinfected with HIV-1. CD16 + monocytes expressed higher CCR5 levels than did CD14 hi /CD16 Ϫ monocytes and were significantly more likely to harbor HIV-1. These data suggest a role for CD16 + monocytes in the pathogenesis of maternal malaria and HIV-1 infections.
Plasmodium falciparum malaria and HIV-1 infection are serious public health concerns for pregnant women in sub-Saharan Africa. Pregnant women are at a greater risk of P. falciparum infection than are nonpregnant women, with up to 50% of pregnant women infected in areas of high transmission [1] . Women of childbearing age are also at a high risk of HIV infection; as a consequence, coinfection with both pathogens is common in the context of pregnancy. HIV-1 infection is associated with higher prevalence and intensity of malaria in pregnancy (reviewed in [2] ); conversely, malaria may augment HIV-1 loads in pregnant women [3] . The impact of each pathogen in the context of coinfection needs to be evaluated.
Peripheral blood monocytes are a heterogeneous population of cells of varying stages of differentiation and activation that are important cellular reservoirs for HIV-1. The majority of monocytes express high levels of CD14 (a component of the lipopolysaccharide receptor complex) but do not express CD16 (a low-affinity receptor for human immunoglobulin G [FcgRIII] ). These cells (hereafter termed "CD14 hi /CD16
Ϫ monocytes") make up most peripheral blood monocytes. Conversely, ∼10% of monocytes express CD16 and variable levels of CD14 [4] (hereafter termed "CD16 + monocytes"). CD16
+ monocytes also express more CCR5 (the coreceptor for cellular entry of R5 strains of HIV-1) than do CD14 hi /CD16
Ϫ monocytes [5] . In response to HIV-1 infection, the CD16 + monocyte subset may expand, particularly in patients with advanced disease or HIV dementia [6] . Our recent study of a cohort of Australian homosexual HIV-positive men [7] showed that monocyte subsets were not significantly altered in individuals with HIV-1 infection receiving antiretroviral therapy but that the proportion of CD16 + monocytes was increased in therapy-naive patients. Thus, the prevalence of this monocyte subset may be a marker for disease severity and/or virological control. By contrast, to our knowledge, there have been no studies addressing monocyte subsets in response to malaria or malaria/HIV coinfection.
In the present study, we investigated the effect of P. hi /CD16 Ϫ and CD16 + monocyte subsets isolated from peripheral blood of 20 HIV-infected pregnant women (see table 1 ). DNA was extracted from monocytes and standardized for cell numbers by realtime PCR for the CCR5 gene. HIV-1 DNA was detected using primers that amplify a highly conserved region of gag. Samples that are denoted by an asterisk showed weak or absent first-round PCR product and were retested using a nested PCR. Samples that were clearly positive for HIV-1 DNA in the first-round PCR were not subjected to nested PCR. The contrast of the photograph of some gel bands has been adjusted only to highlight faint bands for the purposes of publication. Negative control samples (cell lysis buffer only) were also included in all PCR assays and were always negative for contaminating viral DNA (data not shown). 14 Blood was collected in standard K 2 EDTA collection tubes, stored at room temperature, and processed within 24 h of collection. Placental blood was collected by making an incision on the maternal face of the placenta ∼1 cm from the cord insertion and collecting blood that welled from the incision. This procedure results in a mixture of intervillous (i.e., maternal placental) monocytes and fetal blood monocytes from within the villous tree. Cord blood was collected by cord venipuncture. Samples were prepared for flow-cytometric analysis of CD14, CD16, and CCR5 using a whole-blood staining method [8] . Monocytes were initially gated using light-scatter characteristics, then further gated using CD14 and CD16 expression into 3 subsets: CD14 Ϫ and CD16 + monocyte subsets were isolated from 9 mL of peripheral blood from 20 HIV-infected pregnant women (7 coinfected with malaria) using antibody-coated magnetic beads. Peripheral blood mononuclear cells were depleted of T cells using anti-CD3-coated magnetic beads (CD3 Dynabeads; Dynal Biotech), and monocytes were isolated by negative selection using a MACS Monocyte Isolation Kit II (Miltenyi Biotec). CD16 + monocytes were positively enriched from total monocytes (CD16 microbeads; Miltenyi Biotec), whereas the negative fraction represented CD14 hi /CD16 Ϫ monocytes. CD14 hi / CD16
Ϫ and CD16 + monocytes were resuspended in 500 mL of DNA stabilization buffer (Buffer AS1; Qiagen) and stored at Ϫ70ЊC for up to 20 weeks before they were shipped to Melbourne, Australia, at room temperature for analysis. CD14 hi / CD16
Ϫ and CD16 + monocyte cell numbers from each donor were standardized by real-time polymerase chain reaction (PCR) amplification of the CCR5 gene using primers LK46 and LK47 and beacon LK155 [9] . HIV-1 DNA was detected by conventional PCR. Samples were amplified for 40 cycles using primers A2 (sense, 5 -GGGGGACATCAAGCAGCCATGCAAATG-3 ) and B2 (antisense, 5 -ACTCCCTGACATGCTGTCATCATTT-CTTC-3 ). Negative or faintly positive samples were subsequently subjected to nested PCR using primers C2 (sense, 5 -CAGGAACTACTAGTA-3 ) and D2 (antisense, 5 -GAATG- TATAGCCCTA-3 ). Primers showed no base-pair mismatches with the consensus sequence of HIV-1 subtype C, the predominant subtype in Malawi.
Analyses were performed using GraphPad Prism software (version 4.0; GraphPad Software). Multiple groups were analyzed using 1-way analysis of variance (ANOVA) and pairwise comparisons using the Mann-Whitney U test, with Bonferroni's correction to adjust significance levels for multiple comparisons where appropriate. The proportion of samples of CD14 hi / CD16 Ϫ and CD16 + monocytes from which HIV-1 DNA could be amplified was compared using Fisher's exact test.
Results. Participating women ranged in age from 17 to 36 years (mean, 22.2 years) and had gravidity between 1 and 8 (mean, 2.5). Four groups were considered: HIV- (table 1) . Although numbers analyzed were low, we observed that patients in whom HIV-1 DNA was found exclusively in the CD16 + monocytes had higher peripheral blood parasitemia (mean ‫ע‬ SE, parasites/mL; ) 6360 ‫ע‬ 3450 n p 9 than patients in whom HIV-1 DNA was found in both monocyte subsets (none of whom had detectable parasitemia; n p ) or exclusively in the CD16 Ϫ compartment (mean, 945 par-5 asites/mL; range, 195; ). n p 2 Discussion. CD16 + monocytes make up ∼10% of circulating monocytes in healthy nonpregnant adults in developed countries [10] , and this proportion increases during pregnancy [11] . We found higher proportions in the peripheral blood of apparently healthy pregnant and postpartum Malawian women (median, 27.4% and 20.2%, respectively), which suggests that this monocyte subset is expanded irrespective of pregnancy status, compared with that in individuals in developed countries. This may be attributable to the greater prevalence of infectious diseases in Malawi and is consistent with elevated CD16 expression on monocytes in the context of acute infections during pregnancy [11] . A major finding of our study is the expansion of CD16 + monocytes in pregnant women with peripheral malaria parasitemia, which was highest in women coinfected with HIV-1 and was due specifically to the expansion of CD14 lo /CD16 + monocytes. CD16 + monocytes in malariainfected pregnant women may contribute to elevated plasma levels of tumor necrosis factor-a [12] and the consequent pathogenic sequelae observed in gestational malaria. We did not observe significantly higher proportions of CD16 + monocytes in pregnant HIV-1-infected, compared with HIV-1-negative, Malawian women, possibly because of their elevated baseline levels of CD16 + monocytes. CD16 + monocytes expressed higher levels of CCR5, a coreceptor for HIV-1 entry and fusion, than did CD14 hi /CD16 Ϫ monocytes in peripheral, placental, and cord blood. This monocyte subset is more mature than the CD14 hi /CD16 Ϫ subset; with the additional observation of the higher expression of CCR5, these features may explain our finding that CD16 + monocytes were preferentially infected with HIV-1. We have previously shown that monocytes contain multiply spliced HIV-1 RNA and that, therefore, the HIV-1 genome is replication competent within these cells [13] . Infiltration of monocytes into intervillous spaces of the placenta is common in malaria-infected women and correlates with low birth weight and maternal anemia [14, 15] . We hypothesize that CCR5-expressing CD16 + monocytes are responsible for this infiltration. Trafficking of HIV-1-infected CD16
+ monocytes into the placenta may potentially play a role in intrauterine mother-to-child transmission.
